Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 4/4/2020
SIETES contiene 92956 citas

 1 a 20 de 22 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Law SWY, Wong AYS, Anand S, Wong ICK, Chan EW. Neurospychiatric events associated with leukotriene-modifying agents: a systematic review. Drug Saf 2018;41:marzo. [Ref.ID 102559]
2. Cita con resumen
Sing CW, Wong ICK, Cheung BMY, Chan JCY, Chu JKP, Cheung C-L. Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case–control study. Pharmacoepidemiol Drug Saf 2017;26:248-55. [Ref.ID 101954]
3.Enlace a cita original Cita con resumen
Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, Lau WCY, Schuemie MJ, Sturkenboom MCJM, Wong ICK. Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study. BMJ 2017;357:j2350. [Ref.ID 101616]
4.Enlace a cita original
Root AA, Wong AYS, Ghebremichael-Weldeselassie Y, Smeeth L, Bhaskaran K, Evans SJW, Brauer R, Wong ICK, Navaratnam V, Douglas I. Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs. Br J Clin Pharmacol 2016;82:512-21. [Ref.ID 100691]
5.Tiene citas relacionadas Cita con resumen
Wong AYS, Root A, Dogulas IJ, Chui CSL, Chan EW, Ghebremichael-Weldeselassie Y, Siu CW, Smeeth L, Wong ICK. Cardiovascular outcomes associated with use of clarithromycin: population based study. BMJ 2016;352:h6926. [Ref.ID 99982]
6.Enlace a cita original
Rashed AN, Wong ICK, Cranswick N, Tomlin S, Rascher W, Neubert A. Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study. Eur J Clin Pharmacol 2012;68:801-10. [Ref.ID 92826]
7. Cita con resumen
Neubert A, Hsia Y, de Jong-van den Berg LTW, Janhsen K, Glaeske G, Furu K, Kieler H, Norgaard M, Clavenna A, Wong ICK. Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries. Br J Clin Pharmacol 2011;72:969-77. [Ref.ID 91877]
12. Cita con resumen
Sturkenboom MCJM, Verhamme KMC, Nicolosi A, Murray ML, Neubert A, Caudri D, Picelli G, Sen EF, Gianquinto C, Cantarutti L, Baiardi P, Felisi MG, Ceci A, Wong ICK, on behalf of the TEDDY European Network of Excellence. Drug use in children: cohort study in three European countries. BMJ 2008;337:1338-41. [Ref.ID 84656]
Sutcliffe AG, Wong ICK. Rational prescribing for children. BMJ 2006;332:1464-5. [Ref.ID 77389]
Murray ML, Thompson M, Santosh PJ, Wong ICK. Effects of committee on safety of medicines advice on antidepressant prescribing to children and adolescents in the UK. Drug Saf 2005;28:1151-7. [Ref.ID 75833]
Wong ICK, Murray ML. The potential of UK clinical databases in enhancing paediatric medication research. Br J Clin Pharmacol 2005;59:750-5. [Ref.ID 74216]
17. Cita con resumen
Standing JF, Wong ICK. Chlorproguanil-dapsone for malaria. Lancet 2004;364:1752. [Ref.ID 71894]
Wong ICK, Besag FMC, Santosh PJ, Murray ML. Use of selective serotonin reuptake inhibitors in chidlren and adolescents. Drug Saf 2004;27:991-1000. [Ref.ID 71781]
Sweis D, Wong ICK. Giving medicines to children: understanding the parents' views. Pediatr Drugs 2004;6:67-9. [Ref.ID 69470]
Seleccionar todas
 1 a 20 de 22 siguiente >>